RxDoctor Payments Data

Morgan Wyrick, PA

Physician Assistant · Little Rock, ARNPI 1134845746

Payments from drug & device makers

$899in general payments, 2019–2025

Across 54 payments — averaging $16.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$246
  • Alnylam Pharmaceuticals Inc.$79
  • E.r. Squibb & Sons, L.L.C.$78
  • Pfizer$72
  • Novo Nordisk$65
  • Sanofi-aventis U.S. LLC$52
  • plus $308 from 15 others

What the payments were for

  • Food & beverage$83493%
  • Education$657%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$899 in reported general payments places this provider in the 60th percentile of 451 physician assistant providers in Arkansas.

See all physician assistant providers in Arkansas

Medicare billing

Part B allowed, 2024
$42,960
Medicare patients
157
Services billed
2,087

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban127$90,234
EntrestoSacubitril/Valsartan118$84,710
JardianceEmpagliflozin71$59,324
OzempicSemaglutide57$58,955
WegovySemaglutide32$42,203
MounjaroTirzepatide32$34,148
FarxigaDapagliflozin Propanediol32$21,550
XareltoRivaroxaban36$21,448
MultaqDronedarone Hcl16$12,693
CorlanorIvabradine Hcl11$7,635
Clonidine39$5,681
Ranolazine ErRanolazine49$2,692
Midodrine Hcl24$1,940
Carvedilol215$1,354
Torsemide75$1,344

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Wegovy$65$101,15989 claims
PfizerEliquis$72$90,234127 claims
NovartisEntresto$246$84,710118 claims
Lilly USA, LLCMounjaro$15$34,14832 claims
Johnson & JohnsonXarelto$17$21,44836 claims
Sanofi-aventis U.S. LLCMultaq$52$12,69316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 451 physician assistant providers in Arkansas.

Other physician assistant in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →